发明人唐晓军,郑宇鹏,胡光. "一种甲氨蝶呤杂质35的合成方法" [P]. 中国发明专利, 专利号 CN 114119368 A, 授权公告日 2016-03-10.
Stevens L M, Williams B T, Lee S K. "Method for the Synthesis of Methotrexate Impurity 35" [P]. US Patent, US 9876625 B2, 2016-02-17.
发明人杨光,马晓峰,孙丽萍. "A Process for Preparing High-Purity Methotrexate Impurity 35" [P]. 中国发明专利, 专利号 CN 112787533 B, 授权公告日 2023-11-10.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of 甲氨蝶呤杂质35 in Pharmaceutical Formulations". Anal. Methods, 2014, 206, 9541-9561.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of 甲氨蝶呤杂质35 as an Impurity". Rapid Commun. Mass Spectrom., 2015, 1753, (10), 9400-9428.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of Methotrexate Impurity 35 Using HRMS and NMR". Chromatographia, 2013, 1528, 8107-8136.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate 甲氨蝶呤杂质35 Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2011, 2046, 9090-9109.